Page last updated: 2024-08-21

hydrazine and Malignant Mesothelioma

hydrazine has been researched along with Malignant Mesothelioma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Bowyer, S; Brims, F; Chih, HJ; Creaney, J; Fyfe, K; Hawkins, F; Hoon, SN; Jeffery, E; Nowak, A; Peddle-McIntyre, CJ	1
Cominetti, D; De Cesare, M; Deraco, M; Doldi, V; Friedlander, S; Gandellini, P; Kauffman, MG; Landesman, Y; Lopergolo, A; Pennati, M; Shacham, S; Zaffaroni, N	1

Trials

1 trial(s) available for hydrazine and Malignant Mesothelioma

Article	Year
Randomised placebo-controlled cross-over study examining the role of anamorelin in mesothelioma (The ANTHEM study): rationale and protocol. BMJ open respiratory research, 2020, Volume: 7, Issue:1 Topics: Absorptiometry, Photon; Appetite Stimulants; Australia; Body Composition; Cachexia; Clinical Trials, Phase II as Topic; Cross-Over Studies; Double-Blind Method; Humans; Hydrazines; Linear Models; Mesothelioma, Malignant; Muscle Strength; Oligopeptides; Pilot Projects; Quality of Life; Randomized Controlled Trials as Topic; Weight Gain	2020

Article

Year

Randomised placebo-controlled cross-over study examining the role of anamorelin in mesothelioma (The ANTHEM study): rationale and protocol.

BMJ open respiratory research, 2020, Volume: 7, Issue:1

Topics: Absorptiometry, Photon; Appetite Stimulants; Australia; Body Composition; Cachexia; Clinical Trials, Phase II as Topic; Cross-Over Studies; Double-Blind Method; Humans; Hydrazines; Linear Models; Mesothelioma, Malignant; Muscle Strength; Oligopeptides; Pilot Projects; Quality of Life; Randomized Controlled Trials as Topic; Weight Gain

2020

Other Studies

1 other study(ies) available for hydrazine and Malignant Mesothelioma

Article	Year
Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin. Oncotarget, 2015, May-30, Volume: 6, Issue:15 Topics: Acrylamides; Active Transport, Cell Nucleus; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Exportin 1 Protein; G1 Phase Cell Cycle Checkpoints; Humans; Hydrazines; Inhibitor of Apoptosis Proteins; Karyopherins; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Mice; Mice, SCID; Neoplasm Proteins; Oxadiazoles; Peritoneal Neoplasms; Real-Time Polymerase Chain Reaction; Receptors, Cytoplasmic and Nuclear; Survivin; Thiazoles; Triazoles; Tumor Suppressor Protein p53	2015

Article

Year

Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin.

Oncotarget, 2015, May-30, Volume: 6, Issue:15

Topics: Acrylamides; Active Transport, Cell Nucleus; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Exportin 1 Protein; G1 Phase Cell Cycle Checkpoints; Humans; Hydrazines; Inhibitor of Apoptosis Proteins; Karyopherins; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Mice; Mice, SCID; Neoplasm Proteins; Oxadiazoles; Peritoneal Neoplasms; Real-Time Polymerase Chain Reaction; Receptors, Cytoplasmic and Nuclear; Survivin; Thiazoles; Triazoles; Tumor Suppressor Protein p53

2015